DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents

Abstract

By targeting the flap backbone of the BACE1 active site, we discovered 6-dimethylisoxazole-substituted biaryl aminothiazine 18 with 34-fold improved BACE1 inhibitory activity over the lead compound 1. The cocrystal structure of 18 bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap. Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide 26 as a very potent BACE1 inhibitor (IC50 < 1 nM). This compound demonstrated robust brain Aβ reduction in rat dose–response studies. Thus, compound 26 may be useful in testing the amyloid hypothesis of Alzheimer’s disease.

Authors:
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [2];  [2];  [1];  [1];  [1];  [2];  [1]
  1. Bristol-Myers Squibb Company, Wallingford, CT (United States)
  2. Bristol-Myers Squibb Company, Princeton, NJ (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1352260
Resource Type:
Accepted Manuscript
Journal Name:
ACS Medicinal Chemistry Letters
Additional Journal Information:
Journal Volume: 7; Journal Issue: 3; Journal ID: ISSN 1948-5875
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; BACE1; inhibitor; aminothiazine; Aβ42; amyloid hypothesis; Alzheimer’s disease

Citation Formats

Wu, Yong-Jin, Guernon, Jason, Yang, Fukang, Snyder, Lawrence, Shi, Jianliang, Mcclure, Andrea, Rajamani, Ramkumar, Park, Hyunsoo, Ng, Alicia, Lewis, Hal, Chang, ChiehYing, Chang, ChiehYing, Toyn, Jeremy H., Toyn, Jeremy H., Albright, Charles F., Macor, John E., and Thompson, Lorin A. Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents. United States: N. p., 2016. Web. doi:10.1021/acsmedchemlett.5b00432.
Wu, Yong-Jin, Guernon, Jason, Yang, Fukang, Snyder, Lawrence, Shi, Jianliang, Mcclure, Andrea, Rajamani, Ramkumar, Park, Hyunsoo, Ng, Alicia, Lewis, Hal, Chang, ChiehYing, Chang, ChiehYing, Toyn, Jeremy H., Toyn, Jeremy H., Albright, Charles F., Macor, John E., & Thompson, Lorin A. Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents. United States. https://doi.org/10.1021/acsmedchemlett.5b00432
Wu, Yong-Jin, Guernon, Jason, Yang, Fukang, Snyder, Lawrence, Shi, Jianliang, Mcclure, Andrea, Rajamani, Ramkumar, Park, Hyunsoo, Ng, Alicia, Lewis, Hal, Chang, ChiehYing, Chang, ChiehYing, Toyn, Jeremy H., Toyn, Jeremy H., Albright, Charles F., Macor, John E., and Thompson, Lorin A. Thu . "Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents". United States. https://doi.org/10.1021/acsmedchemlett.5b00432. https://www.osti.gov/servlets/purl/1352260.
@article{osti_1352260,
title = {Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents},
author = {Wu, Yong-Jin and Guernon, Jason and Yang, Fukang and Snyder, Lawrence and Shi, Jianliang and Mcclure, Andrea and Rajamani, Ramkumar and Park, Hyunsoo and Ng, Alicia and Lewis, Hal and Chang, ChiehYing and Chang, ChiehYing and Toyn, Jeremy H. and Toyn, Jeremy H. and Albright, Charles F. and Macor, John E. and Thompson, Lorin A.},
abstractNote = {By targeting the flap backbone of the BACE1 active site, we discovered 6-dimethylisoxazole-substituted biaryl aminothiazine 18 with 34-fold improved BACE1 inhibitory activity over the lead compound 1. The cocrystal structure of 18 bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap. Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide 26 as a very potent BACE1 inhibitor (IC50 < 1 nM). This compound demonstrated robust brain Aβ reduction in rat dose–response studies. Thus, compound 26 may be useful in testing the amyloid hypothesis of Alzheimer’s disease.},
doi = {10.1021/acsmedchemlett.5b00432},
journal = {ACS Medicinal Chemistry Letters},
number = 3,
volume = 7,
place = {United States},
year = {Thu Jan 21 00:00:00 EST 2016},
month = {Thu Jan 21 00:00:00 EST 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 27 works
Citation information provided by
Web of Science

Figures / Tables:

Figure 1 Figure 1: Structure of 1 (LY2811376).

Save / Share:

Works referenced in this record:

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
journal, November 1990


Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
journal, February 2007

  • Haass, Christian; Selkoe, Dennis J.
  • Nature Reviews Molecular Cell Biology, Vol. 8, Issue 2
  • DOI: 10.1038/nrm2101

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
journal, April 2014

  • Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian
  • Journal of Neurochemistry, Vol. 130, Issue 1
  • DOI: 10.1111/jnc.12715

The genetics and neuropathology of Alzheimer’s disease
journal, May 2012


A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
journal, July 2012

  • Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy
  • Nature, Vol. 488, Issue 7409
  • DOI: 10.1038/nature11283

Soluble Aβ oligomer production and toxicity: Soluble oligomeric Aβ production and toxicity
journal, November 2011


The secretases: enzymes with therapeutic potential in Alzheimer disease
journal, February 2010


Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
journal, June 2013


Targeting the β secretase BACE1 for Alzheimer's disease therapy
journal, March 2014


The evolution of amidine-based brain penetrant BACE1 inhibitors
journal, May 2014

  • Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 9
  • DOI: 10.1016/j.bmcl.2014.03.025

Robust Central Reduction of Amyloid-  in Humans with an Orally Available, Non-Peptidic  -Secretase Inhibitor
journal, November 2011


3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
journal, October 2011

  • Hewings, David S.; Wang, Minghua; Philpott, Martin
  • Journal of Medicinal Chemistry, Vol. 54, Issue 19
  • DOI: 10.1021/jm200640v

Synthesis of β-disubstituted β-amino isoxazolyl ketones by addition of ketimines with isoxazolyl methyl ketone enolates
journal, March 2014


Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency §
journal, November 2007

  • Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark
  • Journal of Medicinal Chemistry, Vol. 50, Issue 24
  • DOI: 10.1021/jm070829p

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A  Pharmacodynamic Responses in Mice, Dogs, and Humans
journal, January 2015


Works referencing / citing this record:

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics
journal, January 2020

  • Mouchlis, Varnavas D.; Melagraki, Georgia; Zacharia, Lefteris C.
  • International Journal of Molecular Sciences, Vol. 21, Issue 3
  • DOI: 10.3390/ijms21030703

Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality
journal, December 2016

  • Butler, Christopher R.; Ogilvie, Kevin; Martinez-Alsina, Luis
  • Journal of Medicinal Chemistry, Vol. 60, Issue 1
  • DOI: 10.1021/acs.jmedchem.6b01451

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
journal, July 2018